Valter Niemelä
Specialistläkare vid Institutionen för medicinska vetenskaper; Neurologi
- E-post:
- valter.niemela@neuro.uu.se
- Besöksadress:
- Akademiska sjukhuset
- Postadress:
- Akademiska sjukhuset, ing 85 plan 2
751 85 UPPSALA
- Akademiska meriter:
- Med. dr.
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Jag arbetar som neurolog med inriktning mot neurogenetiska sjukdomar och disputerade 2019 med en avhandling om biomarkörer i ryggmärgsvätska vid Huntingtons sjukdom. Jag försöker hitta synergier mellan kliniskt arbetssätt och insamlandet av data för forskning för att förbättra vård och behandling vid neurogenetiska sjukdomar.
Nyckelord
- genetik
- inflammation
- neurobiologi
- neurologi
- neuropsykiatriska funktionsnedsättningar
Publikationer
Senaste publikationer
- Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases (2023)
- Case report (2023)
- Genetic screening for Huntington disease phenocopies in Sweden (2023)
- Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus (2022)
- Sjukdomsmarkörer för Huntingtons sjukdom (2021)
Alla publikationer
Artiklar
- Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases (2023)
- Case report (2023)
- Genetic screening for Huntington disease phenocopies in Sweden (2023)
- Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus (2022)
- Sjukdomsmarkörer för Huntingtons sjukdom (2021)
- Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease (2021)
- Aniridia with PAX6 mutations and narcolepsy (2020)
- Huntingtons sjukdom – kliniska prövningar inger nu optimism (2020)
- Phenotypic variability in chorea-acanthocytosis associated with novel VPS13A mutations (2020)
- High frequency of intermediary alleles in the HTT gene in Northern Sweden (2020)
- Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease (2019)
- Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects (2019)
- Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease (2018)
- Cognitive decline in Huntington’s disease expansion gene carriers (2017)
- Narcolepsy as a side effect of swine flu vaccination (2017)
- Tau or neurofilament light - Which is the more suitable biomarker for Huntington’s disease? (2017)
- Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate (2014)
Böcker
